2Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADR- DA criteria [ J ]. Lancet Neurol, 2007, 6 : 734 - 746.
5Jack CR, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's dis- ease [J]. Alzheimers Dement, 2011, 7:257-262.
6Hort J, O'Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer disease [ J ]. Eur J Neur, 2010, 17:1236 - 1248.
6McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer' s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer' s Disease. Neurology, 1984, 34:939-944.
7Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Neurology, 2001, 56 : 1143-I 153.
8Jack CRJ, Albert M, Knopman DS, et al. Introduction to revised criteria for the diagnosis of Alzheimer' s disease : National Institute on Aging and the Alzheimer Association Workgroups. Alzheimers Dement, 2011,7 :in press.
9Sperling RA, Aisen P, Beckett L, et al. Towards defining the preclinical stage of Alzheimer' s disease: recommendations from the National Institute on Aging and the Alzbeimer' s Association Workgroup. Alzheimers Dement, 2011,7:280-292.
10Albert M, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer' s disease: Report of the National Institute on Aging and the Alzheimer' s Association Workgroup. Alzheimers Dement, 2011,7 : in press.
3Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vasclllar risk factors and Alzheimer's disease in later life: longitudinal, population based study[ J]. Brit Med J,2001,322(7300) :1447 -1451.
4Kivipeho M, Helkala EL, Laakso MP, et al. Apolipoprot~in E epsilon 4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for latelife Alzheimer dis- ease[ J]. Ann Intern Med ,2002,137 ( 3 ) : 149 - 155.
5Plouffe V, Mohamed NV, Rivest-McGraw J, et al. Hyperphosphorylation and cleavage at D421 enhance tausecretion [ J]. PLoS One, 2012,7 (5) : e36873.
7Goate A, Chartie2HarlinM C, Mullan M, et al. Segrega2 tion of a mis- sense mutation in the amyloid precursor protein gene with familia IA lzheime r's disease[ J ]. Na ture,1991,349 :704 -706.
8Bird TD. Genetic factors in Alzheimer's disease [ J ]. N Engl J Med, 2005,352(5) :862 -864.
9Bertram L,McQueen M B,Mullin K,e t al. Systematic me ta2ana lyses ofA lzhe imer disease gene tic association stud2 ie s:the A lzGene da tabase[ J ]. Nat Gene t,2007,39 : 17 - 23.
10Behl C. The search for novel avenues for thetherapy and prevention of Alzheimer's disease[ J]. Drug News Perspect,2006,19( 1 ) :5 - 12.
